Bacterial Skin Infections cream in pharma franchise in Jharkhand

Bacterial Skin Infections cream PCD pharma franchise in Bhubaneswar

Bacterial Skin Infections cream in top pharma company in Indore

Bacterial Skin Infections cream in pcd pharma supplier in Imphal

Bacterial Skin Infections cream in phama franchise company in India
Bacterial Skin Infections cream in phama distributor in Jaipur

Home/Products /ofloxacin-0-point-75-ornidazole-preservatives-cream-cream

About the Product

Description


Diziderm IT Cream is a multi-action topical formulation designed to address a variety of skin infections caused by bacteria, fungi, and inflammation. It combines four active ingredients:

  • Ofloxacin (0.75%): A broad-spectrum antibiotic that inhibits bacterial DNA replication, effectively controlling bacterial infections.
  • Ornidazole (2%): An antiprotozoal and antibacterial agent that treats anaerobic infections and prevents microbial growth.
  • Itraconazole (1%): A potent antifungal that combats fungal infections, particularly those caused by dermatophytes and yeasts.
  • Clobetasol (0.05%): A corticosteroid that reduces inflammation, redness, and itching associated with skin conditions.

This synergistic combination provides comprehensive relief from mixed infections involving bacteria, fungi, and inflammation. It is especially effective for conditions like fungal dermatitis, tinea infections, seborrheic dermatitis, and bacterial superinfections. The addition of preservatives ensures the cream’s stability and effectiveness over time.

The lightweight and easy-to-apply formulation penetrates deeply into the skin, offering rapid relief from symptoms such as itching, redness, scaling, and discomfort. Its multi-pronged approach makes it an essential treatment for dermatological conditions requiring antibacterial, antifungal, and anti-inflammatory actions.

Mild irritation, burning sensation, or redness at the application site may occur. Prolonged use can cause skin thinning or discoloration.

Diziderm IT Cream is indicated for mixed bacterial and fungal skin infections, including tinea infections, fungal dermatitis, and inflammatory skin conditions with secondary infections.

For external use only. Avoid contact with eyes and mucous membranes. Use under medical supervision.

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ofloxacin 0.75% + Ornidazole 2% + Itraconazole 1% + Clobetasole 0.05% Cream in the PCD pharma franchise market?

This multi-action dermatology cream has strong demand in the skin infection and dermatology segment, making it a high-potential product for pharma distributors, wholesalers, and franchise partners. It is widely used in the treatment of mixed bacterial, fungal, and inflammatory skin conditions, which increases its prescription frequency in general practice and dermatology.

Why should medical distributors include this combination cream in their product range? Medical distributors and agencies can benefit from the strong and continuous demand for broad-spectrum dermatology treatments.

Ofloxacin 0.75% provides antibacterial action against skin infections Ornidazole 2% helps in treating anaerobic bacterial and protozoal infections Itraconazole 1% offers effective antifungal coverage Clobetasole 0.05% reduces redness, itching, and inflammation Commonly prescribed for fungal infections, mixed skin infections, dermatitis with infection, and inflammatory skin disorders Provides a triple-action therapeutic approach (antibacterial + antifungal + anti-inflammatory) Strong demand in dermatology clinics and general physician prescriptions This makes it a strong addition to a dermatology-focused product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this cream?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ofloxacin + Ornidazole + Itraconazole + Clobetasole Cream with monopoly rights, marketing support, quality-assured manufacturing, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and franchise partners benefit from high prescription demand in dermatology, repeat purchases for infection cases, wide usage in clinics, stable market demand, and good profit margins due to combination therapy products being commonly prescribed by doctors.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and pharma agencies can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss business terms, obtain monopoly rights for their region, and access a strong dermatology product portfolio backed by reliable supply and promotional support.